Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Important drug interactions in dermatology.

T C Roos1, H F Merk

  • 1Department of Dermatology, University Hospital of the Rheinisch-Westfalische Technische Hochschule, Aachen, Germany.

Drugs
|March 24, 2000
PubMed
Summary

Dermatologists must consider drug interactions, especially those involving cytochrome P450 (CYP) enzymes, to optimize systemic drug therapy for skin conditions. Understanding these interactions improves patient safety and treatment efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aryl hydrocarbon receptor signalling in the skin and adverse vemurafenib effects.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

[Cutaneous side effects of targeted therapies].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

[Acute hypersensitivity reactions associated with monoclonal antibodies for targeted therapy].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

[Lichenoid drug reactions].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature.

Journal of the European Academy of Dermatology and Venereology : JEADV·2016
Same author

[Porphyria cutanea tara].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2016

Area of Science:

  • Pharmacology
  • Dermatology
  • Drug Metabolism

Background:

  • Drug interactions are critical in dermatology due to increased use of systemic therapies.
  • Cytochrome P450 (CYP) enzymes significantly influence drug metabolism, affecting efficacy and adverse events.
  • Individual patient variability in CYP activity impacts drug response.

Purpose of the Study:

  • To review drug interactions relevant to dermatological practice.
  • To highlight the role of CYP enzymes in drug metabolism and interactions.
  • To discuss the impact of pharmacogenetics on optimizing dermatological drug therapy.

Main Methods:

  • Systematic review of pharmacokinetic and pharmacodynamic drug interactions.
  • Focus on drugs commonly used in dermatology.
  • Analysis of drug interactions mediated by CYP isoenzymes.
  • Discussion of pharmacogenetic principles.

Main Results:

  • Drug interactions can occur at all stages of drug disposition (absorption to elimination).
  • CYP-mediated interactions are a major concern, influencing drug concentrations and effects.
  • Pharmacogenetics offers potential for personalized dermatological therapy.

Conclusions:

  • Optimizing dermatological drug therapy requires a thorough understanding of drug interactions.
  • Awareness of CYP enzyme activity and genetic variations is crucial for safe and effective treatment.
  • Pharmacogenetics holds promise for tailoring drug regimens to individual patients.

Related Experiment Videos